why choose us

Clinical Trials Search

Showing 14,280 of 132,656 result(s)
A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement

Status: COMPLETED

Condition: Arthropathy of Knee

Interventions: The intervention group will receive weekly 1-on-1 health coaching with a very-low calorie nutrition plan prior to total knee replacement and a convent

Date: 2023-03-06

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

Status: COMPLETED

Condition: Polymyalgia Rheumatica

Interventions: Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen

Date: 2023-03-06

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

Status: COMPLETED

Condition: Hormone Disturbance

Interventions: 50 minutes of running on a treadmill

Date: 2023-03-06

Avatrombopag vs. Placebo for CIT in GI Malignancies

Status: NOT_YET_RECRUITING

Condition: Gastrointestinal Cancer

Interventions: Thrombopoietin receptor agonist, tablet taken orally.

Date: 2023-03-06

A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Participants will receive intravenous (IV) tobemstomig for four 21-day cycles

Date: 2023-03-06

Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study

Status: Completed

Condition: Huntington Disease

Interventions:

Cohort 1-Huntington's Disease:

The target blood volume of each phlebotomy visit will be 20 mL.
The minimum accepted volume (in the

Date: 2023-03-06

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

Status: Completed

Condition: Hematopoietic and Lymphoid System Neoplasm

Interventions: Receive family letter and genomic test report

Date: 2023-03-06

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Status: Completed

Condition: Advanced Cholangiocarcinoma

Interventions: Undergo collection of blood samples

Date: 2023-03-06

Solriamfetol and CBT-I in Patients With Insomnia Disorder

Status: Completed

Condition: Insomnia

Interventions: Solriamfetol (trade name Sunosi), is a norepinephrine-dopamine reuptake inhibitor available in 75mg and 150mg tablets for oral administration during t

Date: 2023-03-06

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Status: ACTIVE_NOT_RECRUITING

Condition: Platysma Prominence

Interventions: Clostridium botulinum neurotoxin type A (150 kiloDalton [kD], free of complexing proteins) powder for solution for injection.

Date: 2023-03-06